I wonder about the 13 hospital chain acquisition. Sounds like it would be a an extremely costly acquisition. How is it going to be funded? Joe's ability to work deals based on a slice of something huge down the road vs $ now is awesome for these smaller acquisitions but does it work for this scenario?
The successful completion of this acquistion brings a greater level of legitimacy to GNBT IMO. I am not sure it is getting the atention it deserves.
Was there any mention of these hospitals having wound care centers, considering the Excellegen product marketing is being ramped up?
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links